Pancreatic neuroendocrine tumors (PanNETs) lack metabolic zonation due to dense vascularization, showing homogeneous glycolytic phenotypes throughout via aberrant mammalian target of rapamycin (mTOR)-vascular endothelial growth factor (VEGF) crosstalk [7]. The gene discussed is VEGFA; the disease is pancreatic neuroendocrine tumor.